A Systematic Review of the Translation and Validation Methods Used for the National Comprehensive Cancer Network Distress Thermometer in Non-English Speaking Countries
Overview
Psychology
Affiliations
Objective: The National Comprehensive Cancer Network (NCCN) distress thermometer (DT) was developed as a brief screening tool for detecting distress in cancer patients. Conceptually, distress was considered a more acceptable and inclusive term than other psychological terms such as depression or anxiety. It is used extensively in the United States and other English-speaking countries. We aim to describe the translation and validation methods of the DT and describe the recommended cutoff scores used to identify cancer patients experiencing clinically significant distress.
Methods: Nine bibliographic databases were searched using keywords to identify original research studies for non-English speaking countries' cancer patients. Full articles were independently assessed for inclusion and data extraction by two authors.
Results: The review of 4442 articles yielded 39 articles that validated the DT. We identified 20 languages in 25 countries. In all but one country, investigators were able to agree upon a word or phrase that meant distress in their native language that was subsequently validated against standardized instruments. Asian, Middle Eastern and European counties recommended cutoff score of 4 or 5 to identify clinically significant distress; however, European Union countries had a range of 2 to 7.
Conclusions: Use of the translated DT with non-English speaking cancer patients provides a simple and quick tool to identify high distress. Similar to NCCN, the cutoff score of 4 or 5 was suggested by 78% of the studies; however, more studies of different types of cancer and within and among more countries will strengthen a recommended global DT cutoff score.
Perioperative Trends in Distress Among Cancer Patients: A Systematic Review and Meta-Analysis.
Rowe D, OCallaghan E, Yoo S, Dalton J, Woo J, Owolo E Cancer Med. 2025; 14(6):e70456.
PMID: 40079193 PMC: 11904430. DOI: 10.1002/cam4.70456.
Guffi T, Ehrsam J, Debieux M, Rossel J, Crevier M, Reny J BMJ Open. 2024; 14(12):e089662.
PMID: 39732480 PMC: 11683918. DOI: 10.1136/bmjopen-2024-089662.
Afiyanti Y, Juliastuti D, So W, Milanti A, Nasution L, Prawesti A PLoS One. 2024; 19(12):e0299901.
PMID: 39693328 PMC: 11654957. DOI: 10.1371/journal.pone.0299901.
Cheung C, Jones L, Lee H, Bridges J, Tucker-Seeley R, Vyfhuis M Med Res Arch. 2024; 11(10).
PMID: 39036741 PMC: 11258850. DOI: 10.18103/mra.v11i10.4582.
Douglas S, Plow M Int J MS Care. 2023; 25(3):93-98.
PMID: 37250193 PMC: 10211350. DOI: 10.7224/1537-2073.2022-024.